Observational Study Evaluating Outcomes of Hip Arthroplasty Using Tornier Dual Mobility Acetabular Cup
Multicentre, Observational Study Evaluating the Clinical and Radiological Outcomes of Hip Arthroplasty Using the Dual Mobility Cup
1 other identifier
observational
379
0 countries
N/A
Brief Summary
The purpose of this study is to demonstrate the performance and reliability of Tornier "Dual Mobility Cup" used during primary total hip replacement or hip replacement revision surgery at least 24 months post-insertion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2013
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 11, 2014
CompletedFirst Posted
Study publicly available on registry
February 13, 2014
CompletedResults Posted
Study results publicly available
May 16, 2016
CompletedMay 4, 2017
May 1, 2017
6 months
February 11, 2014
December 9, 2015
May 2, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number of Participants With an Implant Dislocation After Surgery
The primary safety outcome (implant dislocation) was assessed by a single question to the patients : Did you experience any implant dislocation since your surgery ? Positive answers were quantified.
2-year postoperative
Percentage of Participants With an Implant Dislocation After Surgery (= Dislocation Rate)
The primary safety outcome (implant dislocation) was assessed by a single question to the patients : Did you experience any implant dislocation since your surgery ? Positive answers were quantified.
2-year postoperative
Implant Survivorship
Implant survivorship criteria was assessed by investigators during patients visits : is the implanted device still in place 2 years after surgery ? Negative answers were quantified.
2-year postoperative
Secondary Outcomes (3)
Clinical Performance - PMA Score
2 years postoperative
Clinical Performance - HOOS Score
2 years postoperative
Clinical Performance - HARRIS Score
2-year postoperative
Study Arms (2)
Primary surgery with Dual Mobility Cup
Patients having a Primary Hip acetabular replacement, using a Dual Mobility Cup.
Revision surgery with Dual Mobility Cup
Patients having a Revision Hip acetabular replacement, using a Dual Mobility Cup.
Interventions
Hip joint replacement with a hip prosthesis including a Dual Mobility cup to replace the acetabular component.
Hip joint replacement with a hip prosthesis including a Dual Mobility cup to replace the acetabular component.
Eligibility Criteria
The global cohort: All the patients who received a Tornier Dual Mobility acetabular cup between October 2010 and October 2011 and who we were able to be contacted by phone. "Primary replacement" group: All the patients who received a Tornier Dual Mobility acetabular cup between October 2010 and October 2011 for primary hip replacement and who were seen for their follow-up visit at 2 years post-procedure. "Revision" group: All patients who received a Tornier Dual Mobility acetabular cup between October 2010 and October 2011 for revision surgery and who were seen for their follow-up visit at 2 years post-procedure. All the performance criteria were analysed for the patients in the "Primary replacement" and "Revision" groups
You may qualify if:
- men and women aged over 18, undergoing total hip replacement with insertion of a Dual Mobility acetabular cup between October 2010 and October 2011,
- capable of attending the 2-year follow-up visit;
- capable of understanding the information about the study and agreeing to take part in it.
You may not qualify if:
- patients with tumoral pathology.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Nathalie TRETOUT
- Organization
- TORNIER SAS
Study Officials
- PRINCIPAL INVESTIGATOR
Christophe Hulet, MD, PR
Caen University Hospital, FR
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 11, 2014
First Posted
February 13, 2014
Study Start
May 1, 2013
Primary Completion
November 1, 2013
Study Completion
December 1, 2013
Last Updated
May 4, 2017
Results First Posted
May 16, 2016
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share